Beckman Coulter recalled its UniCel DxH 800 COULTER Cellular Analysis System on August 13, 2025. This recall affects devices that may produce inaccurately high hemoglobin results in patients with high white blood cell counts. The recall impacts worldwide distribution including numerous states in the U.S. and many countries.
Hematology analyzers configured with HGB photometers may result in erroneously high hemoglobin (HGB) results on samples with elevated white blood cell (WBC) counts.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Beckman Coulter Inc. or your healthcare provider for instructions. Notification method: E-Mail
The recall involves the UniCel DxH 800 COULTER Cellular Analysis System configured with the LED HGB Photometer. The affected model references include B24802, 629029, and B63322. Exact quantities recalled are not specified.
The hematology analyzers may yield erroneously high hemoglobin results in patients with elevated white blood cell counts. This issue can lead to misdiagnosis or inappropriate treatment.
No specific incidents were reported in the recall data. The potential for misdiagnosis poses a serious health risk.
Stop using the UniCel DxH 800 immediately. Healthcare providers should follow the recall instructions from Beckman Coulter Inc. Contact the company or your healthcare provider for further guidance.
Reach Beckman Coulter Inc. via email for assistance. For more information, visit the FDA recall page at the provided URL.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.